. home.aspx



Physician Practice Roundup—AMA urges FTC to monitor insulin pricing

October 30, 2018 / Joanne Finnegan

Concerned about the rapid rise in the price of insulin for patients, the American Medical Association has urged the Federal Trade Commission to monitor insulin pricing and market competition to keep the drug affordable. In a letter to FTC Chairman Joseph Simons, the physician group suggested the FTC recommend enforcement action against manufacturers that engage in anticompetitive actions to the U.S. Department of Justice. The AMA said physicians have become increasingly concerned that the rise in the price of insulin is unrelated to the actual costs of research, development, commercialization or production. Over a nine-year period, gun injuries, including 49% from assaults, sent 75,000 children and teens to the emergency room—over 8,000 cases each year. Over a third of the children were hospitalized and 6% died, according to the study published in JAMA Pediatrics. The study looked at emergency department visits for individuals younger than 18 years for firearm-related injuries be...